Carmen Wängler

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 22

Top Topics

Advanced Non Small Cell Lung Cancer

Positron Emission Tomography

Fluorescence Imaging

Top Venues

Pharmaceuticals (Basel, Switzerland)

Nature protocols

This page only lists publications with an associated author ORCID identifier.

Publications

Diana Braun, Benedikt Judmann, Xia Cheng, Björn Wängler, Ralf Schirrmacher, Gert Fricker, Carmen Wängler
Synthesis, Radiolabeling, and In Vitro and In Vivo Characterization of Heterobivalent Peptidic Agents for Bispecific EGFR and Integrin α v β 3 Targeting. ACS omega 8 (2) (2023)
Güllü Davarci, Carmen Wängler, Klaus Eberhardt, Christopher Geppert, Ralf Schirrmacher, Robert Freudenberg, Marc Pretze, Björn Wängler
Radiosynthesis of Stable 198 Au-Nanoparticles by Neutron Activation of α v β 3 -Specific AuNPs for Therapy of Tumor Angiogenesis. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Güllü Davarci, Carmen Wängler, Klaus Eberhardt, Christopher Geppert, Ralf Schirrmacher, Robert Freudenberg, Marc Pretze, Björn Wängler
Radiosynthesis of Stable 198 Au-Nanoparticles by Neutron Activation of α v β 3 -Specific AuNPs for Therapy of Tumor Angiogenesis. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Benedikt Judmann, Björn Wängler, Ralf Schirrmacher, Gert Fricker, Carmen Wängler
Towards Radiolabeled EGFR-Specific Peptides: Alternatives to GE11. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Diana Braun, Benedikt Judmann, Xia Cheng, Björn Wängler, Ralf Schirrmacher, Gert Fricker, Carmen Wängler
Synthesis, Radiolabeling, and In Vitro and In Vivo Characterization of Heterobivalent Peptidic Agents for Bispecific EGFR and Integrin α v β 3 Targeting. ACS omega 8 (2) (2023)
Helen Damerow, Xia Cheng, Valeska von Kiedrowski, Ralf Schirrmacher, Björn Wängler, Gert Fricker, Carmen Wängler
Toward Optimized 89 Zr-Immuno-PET: Side-by-Side Comparison of [ 89 Zr]Zr-DFO-, [ 89 Zr]Zr-3,4,3-(LI-1,2-HOPO)- and [ 89 Zr]Zr-DFO*-Cetuximab for Tumor Imaging: Which Chelator Is the Most Suitable? Pharmaceutics 14 (10) (2022)
Marco Maspero, Clelia Dallanoce, Björn Wängler, Carmen Wängler, Ralph Hübner
The Exception That Proves the Rule: How Sodium Chelation Can Alter the Charge-Cell Binding Correlation of Fluorescein-Based Multimodal Imaging Agents. ChemMedChem 17 (8) (2022)
Helen Damerow, Björn Wängler, Ralf Schirrmacher, Gert Fricker, Carmen Wängler
Synthesis of a Bifunctional Cross-Bridged Chelating Agent, Peptide Conjugation, and Comparison of 68 Ga Labeling and Complex Stability Characteristics with Established Chelators. ChemMedChem (2022)
Benedikt Judmann, Diana Braun, Ralf Schirrmacher, Björn Wängler, Gert Fricker, Carmen Wängler
Toward the Development of GE11-Based Radioligands for Imaging of Epidermal Growth Factor Receptor-Positive Tumors. ACS omega 7 (31) (2022)
Helen Damerow, Ralph Hübner, Benedikt Judmann, Ralf Schirrmacher, Björn Wängler, Gert Fricker, Carmen Wängler
Side-by-Side Comparison of Five Chelators for 89 Zr-Labeling of Biomolecules: Investigation of Chemical/Radiochemical Properties and Complex Stability. Cancers 13 (24) (2021)
Ralph Hübner, Alexa Paretzki, Valeska von Kiedrowski, Marco Maspero, Xia Cheng, Güllü Davarci, Diana Braun, Helen Damerow, Benedikt Judmann, Vasileios Filippou, Clelia Dallanoce, Ralf Schirrmacher, Björn Wängler, Carmen Wängler
PESIN Conjugates for Multimodal Imaging: Can Multimerization Compensate Charge Influences on Cell Binding Properties? A Case Study. Pharmaceuticals (Basel, Switzerland) 14 (6) (2021)
Lexi Gower-Fry, Travis Kronemann, Andreas Dorian, Yinglan Pu, Carolin Jaworski, Carmen Wängler, Peter Bartenstein, Leonie Beyer, Simon Lindner, Klaus Jurkschat, Björn Wängler, Justin J Bailey, Ralf Schirrmacher
Recent Advances in the Clinical Translation of Silicon Fluoride Acceptor (SiFA) 18F-Radiopharmaceuticals. Pharmaceuticals (Basel, Switzerland) 14 (7) (2021)
Xia Cheng, Ralph Hübner, Valeska von Kiedrowski, Gert Fricker, Ralf Schirrmacher, Carmen Wängler, Björn Wängler
Design, Synthesis, In Vitro and In Vivo Evaluation of Heterobivalent SiFAlin-Modified Peptidic Radioligands Targeting Both Integrin αvβ3 and the MC1 Receptor-Suitable for the Specific Visualization of Melanomas? Pharmaceuticals (Basel, Switzerland) 14 (6) (2021)
Marc Pretze, Valeska von Kiedrowski, Roswitha Runge, Robert Freudenberg, René Hübner, Güllü Davarci, Ralf Schirrmacher, Carmen Wängler, Björn Wängler
αvβ3-Specific Gold Nanoparticles for Fluorescence Imaging of Tumor Angiogenesis. Nanomaterials (Basel, Switzerland) 11 (1) (2021)
Marco Maspero, Xia Cheng, Valeska von Kiedrowski, Clelia Dallanoce, Björn Wängler, Ralph Hübner, Carmen Wängler
Synthesis, Characterization and In Vitro Evaluation of Hybrid Monomeric Peptides Suited for Multimodal Imaging by PET/OI: Extending the Concept of Charge-Cell Binding Correlation. Pharmaceuticals (Basel, Switzerland) 14 (10) (2021)
Ralph Hübner, Xia Cheng, Björn Wängler, Carmen Wängler
Functional Hybrid Molecules for the Visualization of Cancer: PESIN-Homodimers Combined with Multimodal Molecular Imaging Probes for Positron Emission Tomography and Optical Imaging: Suited for Tracking of GRPR-Positive Malignant Tissue*. Chemistry (Weinheim an der Bergstrasse, Germany) 26 (69) (2020)
Ralph Hübner, Valeska von Kiedrowski, Vanessa Benkert, Björn Wängler, Ralf Schirrmacher, Roland Krämer, Carmen Wängler
Hybrid Multimodal Imaging Synthons for Chemoselective and Efficient Biomolecule Modification with Chelator and Near-Infrared Fluorescent Cyanine Dye. Pharmaceuticals (Basel, Switzerland) 13 (9) (2020)
Benedikt Judmann, Diana Braun, Björn Wängler, Ralf Schirrmacher, Gert Fricker, Carmen Wängler
Current State of Radiolabeled Heterobivalent Peptidic Ligands in Tumor Imaging and Therapy. Pharmaceuticals (Basel, Switzerland) 13 (8) (2020)
Korbinian Krieger, Björn Wängler, Ralf Schirrmacher, Carmen Wängler
Identification of a Suitable Peptidic Molecular Platform for the Development of NPY(Y1 )R-Specific Imaging Agents. ChemMedChem 15 (17) (2020)
Simon Lindner, Carmen Wängler, Justin J Bailey, Klaus Jurkschat, Peter Bartenstein, Björn Wängler, Ralf Schirrmacher
Radiosynthesis of [18F]SiFAlin-TATE for clinical neuroendocrine tumor positron emission tomography. Nature protocols 15 (12) (2020)
Ralph Hübner, Vanessa Benkert, Xia Cheng, Björn Wängler, Roland Krämer, Carmen Wängler
Probing two PESIN-indocyanine-dye-conjugates: significance of the used fluorophore. Journal of materials chemistry. B 8 (6) (2020)
Justin J Bailey, Lena Kaiser, Simon Lindner, Melinda Wüst, Alexander Thiel, Jean-Paul Soucy, Pedro Rosa-Neto, Peter J H Scott, Marcus Unterrainer, David R Kaplan, Carmen Wängler, Björn Wängler, Peter Bartenstein, Vadim Bernard-Gauthier, Ralf Schirrmacher
First-in-Human Brain Imaging of [18F]TRACK, a PET tracer for Tropomyosin Receptor Kinases. ACS chemical neuroscience 10 (6) (2019)